Atlas Trials

Precision Dosing of Alemtuzumab

Clinical trial NCT03302754 · COMPLETED

Trial details

NCT number
NCT03302754
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Allogeneic Hematopoietic Cell Transplantation
Start date
2017-10-05
Primary completion
2019-03-10
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.